StonvexLoading…
StonvexCore line items from INR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $154.60M | $150.70M | $350.38M | $234.91M | $156.66M |
Operating Income | Not available | $65.33M | $11.89M | $-42.40M | $-66.30M |
Net Income | Not available | $-1.87M | $13.84M | $-6.84M | $-16.58M |
EPS (Diluted) | $0.85 | $-0.28 | $0.89 | $-0.45 | $-1.09 |
Total Assets | Not available | $2.10B | $1.24B | $1.11B | $1.02B |
Total Liabilities | Not available | $759.80M | $262.93M | $215.56M | $167.31M |
Cash & Equivalents | Not available | $72.98M | $2.85M | $4.57M | $6.28M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 17.66M | 60.95M | 15.30M | 15.24M |